Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 411, doi. 10.1007/s40259-014-0104-3
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2014 AND VI 28 AND IP 4
Results: 9
1
2
siRNA Technology in Kidney Transplantation: Current Status and Future Potential.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 345, doi. 10.1007/s40259-014-0087-0
- By:
- Publication type:
- Article
3
Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 363, doi. 10.1007/s40259-014-0088-z
- By:
- Publication type:
- Article
4
Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 393, doi. 10.1007/s40259-014-0089-y
- By:
- Publication type:
- Article
5
Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 373, doi. 10.1007/s40259-014-0090-5
- By:
- Publication type:
- Article
6
Multi-Specific Antibodies for Cancer Immunotherapy.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 331, doi. 10.1007/s40259-014-0091-4
- By:
- Publication type:
- Article
7
Unexplained Abuses of Human IgG Subclass Denomination in Antibody Patents.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 327, doi. 10.1007/s40259-014-0095-0
- By:
- Publication type:
- Article
8
Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody-Drug Conjugates.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 383, doi. 10.1007/s40259-014-0096-z
- By:
- Publication type:
- Article
9
Ranibizumab: A Review of its Use in Myopic Choroidal Neovascularization.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 403, doi. 10.1007/s40259-014-0102-5
- By:
- Publication type:
- Article